BioSpace News Archive

Verastem, Inc. today announced the grant of options to purchase 6,153 shares of its common stock to one new employee and 40,000 restricted stock units (RSUs) to another new employee.

MV-CHIK met the primary endpoint, eliciting a potent immune response as measured by induction of neutralizing antibodies against Chikungunya, in all treatment groups

AHF condemns Merck for cutting off lifesaving vaccine for children dying from diarrhea in Africa while it also announces plans to expand distribution—and far more lucrative sales—in China

The Medicrea Group announced today that the company will host one-on-one investor meetings during the 9th Annual Craig-Hallum Alpha Select Conference at the Sheraton New York Times Square Hotel on Thursday, November 15, 2018.

KBR, Inc. announced today that its global government services business, KBRwyle, has been awarded a $500 million contract to provide personal services in human performance and behavioral health to the U.S. Special Operations Command (USSOCOM) to support its Preservation of the Force and Family (POTFF) mission.

Scott Wilson Joins Top Cannabis Company As Chief Experience Officer

Highlights Include Beyond Type Run Team NYC Marathon Sponsorship, NASDAQ Closing Bell Ceremony and Global Fundraising Events

Vizient, Inc. is disappointed that the Centers for Medicare and Medicaid Services (CMS) opted to finalize site-neutral payment reductions and the expansion of payment cuts related to the 340B Drug Pricing Program in the final 2019 Outpatient Prospective Payment System (OPPS) rule.

Shoulder Innovations announced today that they have received FDA clearance for their InSet Humeral Short Stem System.

Jardiance (empagliflozin) was associated with a 44 percent reduction in relative risk of hospitalization for heart failure (HHF) compared with commonly used dipeptidyl peptidase-4 inhibitors